Huang Chi-Chou, Chien Wen-Pin, Wong Ruey-Hong, Cheng Ya-Wen, Chen Meng-Cheng, Chou Ming-Chih, Lee Huei
Colorectal Division, Department of Surgery, Chung Shan Medical University Hospital, Taichung, Taiwan, Republic of China.
Dis Colon Rectum. 2007 Jul;50(7):981-9. doi: 10.1007/s10350-007-0230-9.
In Taiwan, colorectal cancer has one of the highest rates of increased incidence in the past two decades. Heterocyclic amines from dietary cooked meats are metabolically activated by NAT2 (N-acetyltransferase 2), which are associated with colorectal cancer incidence. Thus, the NAT2 fast acetylator genotype may be associated with colorectal cancer risk. However, the association between the NAT2 genotype and colorectal cancer risk is not clearly understood. We conducted a study with 244 primary colorectal cancer cases and 299 cancer-free healthy control subjects to verify the association of NAT2 polymorphisms with the risk of Taiwanese colorectal cancer. Our data showed that subjects with the NAT2 W/W homozygous genotype had a 1.63-fold increased risk of colorectal cancer compared with those with the Mx/Mx slow acetylator genotype (95 percent confidence interval, 1.03-2.58); however, no risk was found in the W/Mx heterozygous and Mx/W+W/W fast acetylator genotypes. Being stratified by gender factors, the colorectal cancer risk in females with homozygous W/W or Mx/W+W/W fast acetylators increased 2.47-fold and 2.13-fold compared with those with the Mx/Mx slow acetylator genotype (95 percent confidence interval, 1.27-4.82 for W/W genotype; 95 percent confidence interval, 1.17-3.89 for Mx/W+W/W genotype); however, the risk of the NAT2 genotype and colorectal cancer was not observed in males. Collectively, patients with the NAT2 fast acetylator genotype were more prone to colorectal cancer and reflected the possibility that exposure to heterocyclic amines may contribute to colorectal cancer development in Taiwan, especially in Taiwanese females.
在台湾,结直肠癌是过去二十年来发病率上升幅度最高的癌症之一。饮食中熟肉所含的杂环胺可被N - 乙酰基转移酶2(NAT2)代谢激活,这与结直肠癌的发病率相关。因此,NAT2快速乙酰化酶基因型可能与结直肠癌风险有关。然而,NAT2基因型与结直肠癌风险之间的关联尚不清楚。我们对244例原发性结直肠癌患者和299例无癌健康对照者进行了一项研究,以验证NAT2基因多态性与台湾人患结直肠癌风险之间的关联。我们的数据显示,与具有Mx/Mx慢乙酰化酶基因型的受试者相比,具有NAT2 W/W纯合基因型的受试者患结直肠癌的风险增加了1.63倍(95%置信区间,1.03 - 2.58);然而,在W/Mx杂合基因型和Mx/W + W/W快速乙酰化酶基因型中未发现风险。按性别因素分层后,与具有Mx/Mx慢乙酰化酶基因型的女性相比,具有W/W纯合或Mx/W + W/W快速乙酰化酶基因型的女性患结直肠癌的风险分别增加了2.47倍和2.13倍(W/W基因型的95%置信区间为1.27 - 4.82;Mx/W + W/W基因型的95%置信区间为1.17 - 3.89);然而,在男性中未观察到NAT2基因型与结直肠癌之间的风险关联。总体而言,具有NAT2快速乙酰化酶基因型的患者更容易患结直肠癌,这反映出在台湾,尤其是台湾女性中,接触杂环胺可能会促使结直肠癌的发生。